Financial results - VERSUS MED SRL

Financial Summary - Versus Med Srl
Unique identification code: 10648000
Registration number: J22/587/1998
Nace: 4646
Sales - Ron
101.464
Net Profit - Ron
35.085
Employee
2
The most important financial indicators for the company Versus Med Srl - Unique Identification Number 10648000: sales in 2023 was 101.464 euro, registering a net profit of 35.085 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Comert cu ridicata al produselor farmaceutice having the NACE code 4646.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Versus Med Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 313.027 244.545 268.020 - 140.575 113.343 230.737 22.965 71.530 101.464
Total Income - EUR 314.959 246.527 323.676 - 162.894 157.272 240.142 47.233 72.610 105.616
Total Expenses - EUR 264.206 216.312 365.218 - 125.905 105.708 178.826 85.162 61.590 69.536
Gross Profit/Loss - EUR 50.753 30.215 -41.541 - 36.988 51.564 61.315 -37.930 11.019 36.080
Net Profit/Loss - EUR 41.725 24.175 -44.361 - 35.359 50.052 59.101 -38.402 10.302 35.085
Employees 2 1 1 - 1 1 1 1 1 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 42.3%, from 71.530 euro in the year 2022, to 101.464 euro in 2023. The Net Profit increased by 24.814 euro, from 10.302 euro in 2022, to 35.085 in the last year.

Check the financial reports for the company - Versus Med Srl

Rating financiar

Financial Rating -
Versus Med Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Versus Med Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Versus Med Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Versus Med Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Versus Med Srl - CUI 10648000

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 135.089 131.796 968 - 0 0 5.710 4.025 2.475 909
Current Assets 271.373 259.761 190.075 - 158.634 142.897 161.038 32.137 79.082 101.371
Inventories 41.316 46.277 65.087 - 58.854 58.400 58.921 20.662 23.629 39.446
Receivables 156.021 161.166 66.944 - 80.749 38.233 50.344 10.707 53.021 58.340
Cash 74.037 52.318 58.044 - 19.030 46.264 51.774 768 2.433 3.585
Shareholders Funds 228.417 257.961 54.696 - 71.711 129.049 79.572 -26.818 -17.218 17.919
Social Capital 45 45 45 - 43 42 41 40 41 40
Debts 178.046 133.596 136.347 - 86.922 13.848 87.176 62.980 98.775 84.361
Income in Advance 0 0 0 - 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 101.371 euro in 2023 which includes Inventories of 39.446 euro, Receivables of 58.340 euro and cash availability of 3.585 euro.
The company's Equity was valued at 17.919 euro, while total Liabilities amounted to 84.361 euro. Equity increased by 35.085 euro, from -17.218 euro in 2022, to 17.919 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Versus Med Srl

Comments - Versus Med Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.